Skip to main content
Log in

Efficacy and Safety of Emodepside 2.1 %/Praziquantel 8.6% Spot-on Formulation in the Treatment of Feline Aelurostrongylosis

  • Published:
Parasitology Research Aims and scope Submit manuscript

Abstract

The objective of the present study was to evaluate the efficacy and safety of the antiparasitic spot-on formulation containing emodepside 2.1 %/praziquantel 8.6% (Profender®, Bayer) in the treatment of natural feline infection with the lungworm Aelurostrongylus abstrusus (Nematoda, Strongylida). Efficacy of Profender® given once at the licensed dose was tested in comparison to a control oral formulation containing fenbendazole 18.75 % (Panacur®, Intervet) given over three consecutive days at the licensed dose. Efficacy assessment was based on larvae per gramme of faeces (LPG) counts, measured on days 28 ± 2 following treatment and compared to counts on days –6 to –2. In total 24 cats treated either with Profender® (n = 12) or with Panacur (n = 12) were included in the assessment of efficacy and safety. Mean LPG post-baseline counts (days 28 ± 2) were 1.3 LPG for both Profender® and Panacur®, demonstrating similar efficacy of 99.38 % for Profender® and 99.29 % for the control product. No treated animals showed adverse events. This trial demonstrated that both Profender® spot-on formulation and oral paste Panacur® are safe and effective in the treatment of aelurotrongylosis in cats. Future practical perspectives in feline medicine and the major advantages of the spot-on product compared to the oral paste are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Barrs VR, Swinney GR, Martin P, Nicoll RG (1999) Concurrent Aelurostrongylus abstrusus infection and salmonellosis in a kitten. Aust Vet J 77:229–232

    Article  PubMed  CAS  Google Scholar 

  • Blagburn BL, Hendrix CM, Lindsay DS, Vaughan JL (1987) Anthelmintic efficacy of ivermectin in naturally parasitized cats. Am J Vet Res 48:670–672

    PubMed  CAS  Google Scholar 

  • Clayton HM (1983) The management and treatment of respiratory nematode infections in small animals. Vet Ann 23:254–259

    Google Scholar 

  • Euzeby J (1981) La coprologie chez les carnivores. In: Diagnostic expérimental des helminthoses animales. Travaux pratiques d’helminthologie vétérinaire, Livre 1, Informations Techniques des Services Vétérinaires, Paris, France.

  • Grandi G, Calvi LE, Venco L, Paratici C, Genchi C, Memmi D, Kramer LH (2005) Aelurostrongylus abstrusus (cat lungworm) infection in five cats from Italy. Vet Parasitol 134:177–182

    Article  PubMed  CAS  Google Scholar 

  • Hamilton JM, Weatherley A, Chapman AJ (1984) Treatment of lungworm disease in the cat with fenbendazole. Vet Rec 114:40–41

    PubMed  CAS  Google Scholar 

  • Harder A, von Samson-Himmelstjerna G (2002) Cyclooctadepsipeptides–a new class of anthelmintically active compounds. Parasitol Res 88:481–488

    Article  PubMed  Google Scholar 

  • Kirkpatrick CE, Megella C (1987) Use of ivermectin in treatment of Aelurostrongylus abstrusus and Toxocara cati infection in a cat. J Am Vet Med Assoc 190:1309–1310

    PubMed  CAS  Google Scholar 

  • Lewis DT, Merchant SR, Neer TM (1994) Ivermectin toxicosis in a kitten. J Am Vet Med Assoc 205:584

    PubMed  CAS  Google Scholar 

  • Miller BH, Roudebush P, Nard HG (1984) Pleural effusion as a sequel to aelurostrongylosis in a cat. J Am Vet Med Assoc 185:556–557

    PubMed  CAS  Google Scholar 

  • Roberson EL, Burke TM (1980) Evaluation of granulated fenbendazole (22.2%) against induced and naturally occurring helminth infections in cats. Am J Vet Res 41:1499–1502

    PubMed  CAS  Google Scholar 

  • Schmid K, Duewel D (1990) Use of fenbendazole (Panacur® tablets ad. us. vet.) against helminth infections in cats. Tieraerztl Umsch 45:873–875

    Google Scholar 

  • Scott DW (1972) Current knowledge of Aelurostrongylus abstrusus in the cat. Cornell Vet 63:483–500

    Google Scholar 

  • Sloss MW, Kemp RL, Zajac AM (1994) Fecal examination: dogs and cats. In: Veterinary Clinical Parasitology, 6th edn., Iowa State University Press, Ames, USA.

  • Traversa D, Guglielmini C (2008) Feline aelurostrongylosis and canine angiostrongylosis: a challenging diagnosis for two emerging verminous pneumonia infections. Vet Parasitol 157:163–174

    Article  PubMed  Google Scholar 

  • Traversa D, Di Cesare A, Milillo P, Lohr B, Iorio R, Pampurini F, Schaper R, Paoletti B, Heine J (2009) Efficacy and safety of imidacloprid 10 % / moxidectin 1 % spot-on formulation in the treatment of feline aelurostrongylosis. Parasitol Res 105(1):S55–S62

    Article  Google Scholar 

  • VICH guideline 9: Good clinical practice. Veterinary International Cooperation on Harmonization, European Agency for the Evaluation of Medicinal Products, London, July 2000.

  • VICH guideline 19: Efficacy of anthelmintics: specific recommendations for canine. Veterinary International Cooperation on Harmonization, European Agency for the Evaluation of Medicinal Products, London, July 2001.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Donato Traversa.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Traversa, D., Milillo, P., Di Cesare, A. et al. Efficacy and Safety of Emodepside 2.1 %/Praziquantel 8.6% Spot-on Formulation in the Treatment of Feline Aelurostrongylosis. Parasitol Res 105 (Suppl 1), 83–90 (2009). https://doi.org/10.1007/s00436-009-1499-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00436-009-1499-5

Keywords

Navigation